Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons.

Capela JP, da Costa Araújo S, Costa VM, Ruscher K, Fernandes E, Bastos Mde L, Dirnagl U, Meisel A, Carvalho F.

Neurotoxicology. 2013 Jan;34:254-63. doi: 10.1016/j.neuro.2012.09.005. Epub 2012 Sep 13.

PMID:
22983118
2.

Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia.

Capela JP, Ruscher K, Lautenschlager M, Freyer D, Dirnagl U, Gaio AR, Bastos ML, Meisel A, Carvalho F.

Neuroscience. 2006;139(3):1069-81. Epub 2006 Feb 28.

PMID:
16504407
3.

Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

Capela JP, Fernandes E, Remião F, Bastos ML, Meisel A, Carvalho F.

Neurotoxicology. 2007 Jul;28(4):868-75. Epub 2007 Apr 27.

PMID:
17572501
4.

Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures.

Nogueira TB, da Costa Araújo S, Carvalho F, Pereira FC, Fernandes E, Bastos ML, Costa VM, Capela JP.

Neuroscience. 2014 Sep 26;277:417-34. doi: 10.1016/j.neuroscience.2014.07.009. Epub 2014 Jul 15.

PMID:
25047998
5.

The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.

Barbosa DJ, Serrat R, Mirra S, Quevedo M, de Barreda EG, Àvila J, Ferreira LM, Branco PS, Fernandes E, Lourdes Bastos Md, Capela JP, Soriano E, Carvalho F.

Toxicol Sci. 2014 Jun;139(2):407-20. doi: 10.1093/toxsci/kfu042. Epub 2014 Mar 4.

PMID:
24595818
6.

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Baumann MH, Wang X, Rothman RB.

Psychopharmacology (Berl). 2007 Jan;189(4):407-24. Epub 2006 Mar 16. Review.

7.

Neurotoxicity mechanisms of thioether ecstasy metabolites.

Capela JP, Macedo C, Branco PS, Ferreira LM, Lobo AM, Fernandes E, Remião F, Bastos ML, Dirnagl U, Meisel A, Carvalho F.

Neuroscience. 2007 Jun 8;146(4):1743-57. Epub 2007 Apr 30.

PMID:
17467183
8.

Glial cell response to 3,4-(+/-)-methylenedioxymethamphetamine and its metabolites.

Herndon JM, Cholanians AB, Lau SS, Monks TJ.

Toxicol Sci. 2014 Mar;138(1):130-8. doi: 10.1093/toxsci/kft275. Epub 2013 Dec 3.

9.
10.

"Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.

Barbosa DJ, Capela JP, Silva R, Ferreira LM, Branco PS, Fernandes E, Bastos ML, Carvalho F.

Arch Toxicol. 2014 Feb;88(2):515-31. doi: 10.1007/s00204-013-1147-9. Epub 2013 Nov 1.

PMID:
24177245
11.

Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.

Achat-Mendes C, Ali SF, Itzhak Y.

Neuropsychopharmacology. 2005 Jun;30(6):1128-37.

12.

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.

Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR.

Br J Pharmacol. 2002 Jan;135(1):170-80.

13.

Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].

Ross JD, Herin DV, Frankel PS, Thomas ML, Cunningham KA.

Drug Alcohol Depend. 2006 Feb 1;81(2):117-27. Epub 2005 Jul 28.

PMID:
16054778
14.

Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia.

Capela JP, Meisel A, Abreu AR, Branco PS, Ferreira LM, Lobo AM, Remião F, Bastos ML, Carvalho F.

J Pharmacol Exp Ther. 2006 Jan;316(1):53-61. Epub 2005 Sep 23.

15.

Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure.

Warren MW, Zheng W, Kobeissy FH, Cheng Liu M, Hayes RL, Gold MS, Larner SF, Wang KK.

Int J Neuropsychopharmacol. 2007 Aug;10(4):479-89. Epub 2006 Aug 2.

PMID:
16882358
16.

Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy.

Alvaro AR, Martins J, Costa AC, Fernandes E, Carvalho F, Ambrósio AF, Cavadas C.

Neuroscience. 2008 Mar 3;152(1):97-105. doi: 10.1016/j.neuroscience.2007.12.027.

PMID:
18249070
17.

Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Halpin LE, Collins SA, Yamamoto BK.

Life Sci. 2014 Feb 27;97(1):37-44. doi: 10.1016/j.lfs.2013.07.014. Epub 2013 Jul 24. Review.

18.

Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function.

Custódio JB, Santos MS, Gonçalves DI, Moreno AJ, Fernandes E, Bastos ML, Carvalho F, Vicente JA, Fernandes MA.

Toxicology. 2010 Apr 11;270(2-3):99-105. doi: 10.1016/j.tox.2010.01.022. Epub 2010 Feb 6.

PMID:
20138954
19.

The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.

Monks TJ, Jones DC, Bai F, Lau SS.

Ther Drug Monit. 2004 Apr;26(2):132-6. Review.

PMID:
15228153
20.

Supplemental Content

Support Center